These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23159988)

  • 1. Nuclear receptors, bile acids and cholesterol homeostasis series - bile acids and pregnancy.
    Abu-Hayyeh S; Papacleovoulou G; Williamson C
    Mol Cell Endocrinol; 2013 Apr; 368(1-2):120-8. PubMed ID: 23159988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid.
    Brites D
    Ann Hepatol; 2002; 1(1):20-8. PubMed ID: 15114292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intrahepatic cholestasis of pregnancy: a disorder of increased fetal risks. Part I. Maternal condition].
    Jóźwik M; Jóźwik M; Bartnicki J; Jóźwik M
    Ginekol Pol; 2007 Apr; 78(4):312-6. PubMed ID: 17621995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acid patterns in meconium are influenced by cholestasis of pregnancy and not altered by ursodeoxycholic acid treatment.
    Rodrigues CM; Marín JJ; Brites D
    Gut; 1999 Sep; 45(3):446-52. PubMed ID: 10446117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Insights on Intrahepatic Cholestasis of Pregnancy.
    Floreani A; Gervasi MT
    Clin Liver Dis; 2016 Feb; 20(1):177-89. PubMed ID: 26593298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe.
    Ambros-Rudolph CM; Glatz M; Trauner M; Kerl H; Müllegger RR
    Arch Dermatol; 2007 Jun; 143(6):757-62. PubMed ID: 17576942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta.
    Serrano MA; Brites D; Larena MG; Monte MJ; Bravo MP; Oliveira N; Marin JJ
    J Hepatol; 1998 May; 28(5):829-39. PubMed ID: 9625319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin-releasing hormone expression in patients with intrahepatic cholestasis of pregnancy after ursodeoxycholic acid treatment: an initial experience.
    Zhou F; Zhang L; He MM; Liu ZF; Gao BX; Wang XD
    Curr Med Res Opin; 2014 Aug; 30(8):1529-35. PubMed ID: 24665980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal death in a patient with intrahepatic cholestasis of pregnancy.
    Sentilhes L; Verspyck E; Pia P; Marpeau L
    Obstet Gynecol; 2006 Feb; 107(2 Pt 2):458-60. PubMed ID: 16449148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intrahepatic cholestasis of pregnancy: review].
    Medina Lomelí JM; Jáuregui Meléndrez RA; Medina Castro N; Medina Castro D
    Ginecol Obstet Mex; 2012 Apr; 80(4):285-94. PubMed ID: 22808859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy [see comemnts].
    Brites D; Rodrigues CM
    J Hepatol; 1998 Nov; 29(5):743-51. PubMed ID: 9833912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical grading of intrahepatic cholestasis pregnancy.
    Pradhan M; Shao Y
    JNMA J Nepal Med Assoc; 2013; 52(190):413-9. PubMed ID: 24362672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy.
    Van Mil SW; Milona A; Dixon PH; Mullenbach R; Geenes VL; Chambers J; Shevchuk V; Moore GE; Lammert F; Glantz AG; Mattsson LA; Whittaker J; Parker MG; White R; Williamson C
    Gastroenterology; 2007 Aug; 133(2):507-16. PubMed ID: 17681172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart and bile acids - Clinical consequences of altered bile acid metabolism.
    Vasavan T; Ferraro E; Ibrahim E; Dixon P; Gorelik J; Williamson C
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1345-1355. PubMed ID: 29317337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy.
    Meng LJ; Reyes H; Axelson M; Palma J; Hernandez I; Ribalta J; Sjövall J
    Hepatology; 1997 Dec; 26(6):1573-9. PubMed ID: 9398000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular mechanisms of bile formation and cholestatic diseases].
    Poupon R
    Bull Acad Natl Med; 2003; 187(7):1261-74; discussion 1274-6. PubMed ID: 15146603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy.
    Kondrackiene J; Beuers U; Kupcinskas L
    Gastroenterology; 2005 Sep; 129(3):894-901. PubMed ID: 16143129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid.
    Glantz A; Marschall HU; Lammert F; Mattsson LA
    Hepatology; 2005 Dec; 42(6):1399-405. PubMed ID: 16317669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrahepatic cholestasis of pregnancy.
    Pusl T; Beuers U
    Orphanet J Rare Dis; 2007 May; 2():26. PubMed ID: 17535422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers.
    Mazzella G; Rizzo N; Azzaroli F; Simoni P; Bovicelli L; Miracolo A; Simonazzi G; Colecchia A; Nigro G; Mwangemi C; Festi D; Roda E
    Hepatology; 2001 Mar; 33(3):504-8. PubMed ID: 11230728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.